Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study
Porter, D.P.; Daeumer, M.; Thielen, A.; Chang, S.; Martin, R.; Cohen, C.; Miller, M.D.; White, K.L. Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study. Viruses 2015, 7, 6360-6370. https://doi.org/10.3390/v7122943
Porter DP, Daeumer M, Thielen A, Chang S, Martin R, Cohen C, Miller MD, White KL. Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study. Viruses. 2015; 7(12):6360-6370. https://doi.org/10.3390/v7122943
Chicago/Turabian StylePorter, Danielle P., Martin Daeumer, Alexander Thielen, Silvia Chang, Ross Martin, Cal Cohen, Michael D. Miller, and Kirsten L. White. 2015. "Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study" Viruses 7, no. 12: 6360-6370. https://doi.org/10.3390/v7122943